Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer ...

Novo Nordisk, under new leadership and needing a boost, is cutting 11% of its workforce as it tries to regain its footing in ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

If you’re eyeing Novo Nordisk stock right now, you’re not alone. Investors have been left scratching their heads as to what comes next, after several twists in the company’s share price. In the past ...